- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Personalis Inc.
Headquarters: Menlo Park, CA, United States
Website: http://www.personalis.com
Year Founded: 2011
Status: Public
Industry Sector: HealthServices
CEO: Christopher M. Hall, MBA
Number Of Employees: 229
Enterprise Value: $201,811,855
PE Ratio: -3.74
Exchange/Ticker 1: NASDAQ:PSNL
Exchange/Ticker 2: N/A
Latest Market Cap: $425,726,976
BioCentury | Mar 3, 2023
Management Tracks
Delaney leaving Aadi as CEO
Plus: new CEO of Personalis, and Shaulis made commercial head and president of Hansa’s U.S. affiliate
BioCentury | Jul 1, 2022
Finance
After Forty Seven takeout, MacQuitty finding ‘freedom’ with Lightspeed team
Hybrid firm’s ‘leap’ backing Stanford spinout spurred more life sciences deals, with onetime Abingworth partner building team and portfolio
BioCentury | Apr 15, 2022
Discovery & Translation
Oncolytic viruses boost CAR Ts; plus Personalis and more
BioCentury’s roundup of translational news
BioCentury | Mar 28, 2022
Management Tracks
Asif Ali to join Protagonist as CFO
Plus new CMO at Avenge Bio, new CEO at
BioCentury | Jun 20, 2020
Management Tracks
Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more
BioCentury | May 6, 2020
Management Tracks
Abrams resigns as Editas CMO; plus Immunocore, Spruce, Frazier, Horama and more
BioCentury | Jul 13, 2019
Finance
How crossover, insider support and big money correlated with performance across 1H19 IPOs
Big money and crossover support continue to drive IPO performance in 1H19
BioCentury | Jun 29, 2019
Finance
Specialists and strong fundamentals must carry the sector in 3Q19
With generalists out and little exciting news, specialists still in the game are betting on strong fundamentals
BioCentury | Jun 20, 2019
Financial News
New listings push IPO pace ahead of last year’s
Five new listings on NASDAQ suggest persistent appetite for biotech IPOs
Items per page:
1 - 10 of 21